Epidemiology from Literature | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | 1.10 - Any allergy symptom, Diagnosed | 2014 | Brazil | IgE | 49 | 31.000 | 20141118, Santiago HD
| 1.10 - Any allergy symptom, Diagnosed | 2014 | Brazil | IgE | 37 | 10.800 | 20141118, Santiago HD
| 1.4 - Respiratory Symptoms, Diagnosed | 2014 | Austria | IgE | 42 | 24.000 | 20140707, Banerjee S
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Austria | IgE | 5 | 33.000 | 20140707, Banerjee S
| 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Germany | IgE | 100 | 22.000 | 20140707, Banerjee S
| 3.2.1 - Source Sensitized (IgE) | 2003 | Austria | IgE | 20 | 0.000 | | 3.2.1 - Source Sensitized (IgE) | 2010 | United States | IgE | 21 | 100.000 | 20100315, Mueller GA
| 3.2.1 - Source Sensitized (IgE) | 2003 | Zimbabwe | IgE | 20 | 35.000 | | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2008 | Sweden | IgE | 31 | 13.000 | 20081121, Weghofer M
| 5.2.1 - Source Exposed (Symptoms, SPT) | 2004 | Australia / Austria | IgE | 78 | 26.900 | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1998 | Venezuela | SPT | 150 | 57.000 | | 5.2.1 - Source Exposed (Symptoms, SPT) | 1997 | Venezuela | SPT | 60 | 52.000 | | 5.2.3 - Source Exposed, Children (Symptoms, SPT) | 1996 | Taiwan | IgE | 41 | 46.300 | | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2006 | Australia | IgE | 105 | 30.500 | 20060524, Hales BJ
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2006 | Australia | IgE | 77 | 44.200 | 20060524, Hales BJ
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Austria | IgE | 56 | 32.000 | 20081121, Weghofer M
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2007 | Colombia | IgE | 90 | 15.600 | 20080220, Jimenez S
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | France | IgE | 55 | 24.000 | 20081121, Weghofer M
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Italy | IgE | 67 | 48.000 | 20081121, Weghofer M
| 5.3.1 - Source Exposed (Symptoms, IgE) | 2008 | Sweden | IgE | 65 | 17.000 | 20081121, Weghofer M
| 5.3.1 - Source Exposed (Symptoms, IgE) | 1997 | Venezuela | IgE | 56 | 40.000 | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Australia | IgE | 37 | 49.000 | 20121018, Hales BJ
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Austria | IgE | 62 | 28.420 | 20110629, Resch Y
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | France | IgE | 19 | 21.050 | 20120622, Casset A
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Italy | IgE | 26 | 30.770 | 20120622, Casset A
| 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Singapore | IgE | 225 | 15.000 | 20110221, Kidon MI
|
|